Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Nephrology | Family Medicine | Urology
Search Medical Condition
Benign Prostatic Hyperplasia (Enlarged Prostate) Clinical Trials
A listing of Benign Prostatic Hyperplasia (Enlarged Prostate) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (46) clinical trials
A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Investigate the Efficacy and Safety of Fedovapagon in the Treatment of Nocturia in Men with Benign Prostatic Hyperplasia (BPH)
Receive Redovapagon or Placebo for the treatment of nocturia
Study to investigate the efficacy and safety of an investigational medication in the treatment of nocturia in men with BPH (prostate enlargement)
Study to investigate the effectiveness and safety of an investigational medication in the treatment of nocturia in men with BPH (prostate enlargement)
Confirm the efficacy of PRX302 in reducing lower urinary tract symptoms (LUTS) in patients with benign prostatic hyperplasia (BPH).
This is a prospective, randomized, double-blind, vehicle-controlled, parallel 2-arm, multi-center, multinational Phase III study of the efficacy and safety of a single intraprostatic injection of PRX302 in reducing LUTS in patients with BPH.
PLUS 1 Study
A randomized double-blinded vehicle controlled multi-center safety and efficacy study of a single intraprostatic treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Men With Ejaculatory Problems
University Urology is currently enrolling men 26 years or older who experience problems with ejaculation. You may qualify for the study if you are unable to ejaculate (cum) at all, it takes you a long time to ejaculate, you experience decrease force of ejaculation and/or decrease volume (amount) of ejaculate. ...
A Phase III multi-center prospective randomized, parallel-group, placebo-controlled, double-blind, clinical evaluation of NX-1207 for the treatment of BPH (Benign Prostatic Hyperplasia, or Enlarged Prostate)
The purpose of this study is to evaluate the efficacy and safety of NX-1207 and to see if it could be useful for men with BPH. The study treatment will consist of either an injection of NX-1207 or of a placebo into the prostate. If you end up receiving the ...
Enlarged Prostate or BPH
Enjoy Your Time BPH not only interferes with your health, it can disrupt your lifestyle. Common BPH symptoms are: Frequent urination with urgency, especially at night Felling bladder does not completely empty Difficulty starting Weak or intermittent stream Our physicians are conducting a research study to see if an investigational ...
Benign Prostatic Hyperplasia (Enlarged Prostate)
Northern California Research is conducting a study for Benign Prostatic Hyperplasia (BPH). The purpose of the study to see whether or not the study medication will reduce the size of the prostate in men with enlarged prostates with urinary tract symptoms, and to see its effects on a blood marker ...
Effectiveness of onaBoNT-A vs Oral Tamsulosin in Men With Benign Prostatic Hyperplasia and Lower Urinary Track Symptoms (BPH)
This proposed intervention is the first randomized clinical trial comparing the effects of onaBoNT-A prostate injection versus alpha adrenergic antagonist medication for LUTS associated with BPH. Up to this point, clinical studies using onaBoNT-A in the prostate has been limited to patient's refractory to -1 adrenoceptor blocker therapy. The study ...
A Study to Evaluate the Efficacy Safety and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
At Screening (Visit 1), subjects will enter into a 4-week open label tamsulosin hydrochloride 0.4 mg QD run-in period prior to being randomized into the 12-week double-blind treatment period (Visit 2). At conclusion of the 4-week tamsulosin hydrochloride run-in period, subjects will complete a 3-day diary just prior to Baseline ...
